| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 494 | 2019 |
| The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa M Lemoine, Y Shimakawa, S Nayagam, M Khalil, P Suso, J Lloyd, ... Gut 65 (8), 1369-1376, 2016 | 390 | 2016 |
| Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study M Lemoine, Y Shimakawa, R Njie, M Taal, G Ndow, I Chemin, S Ghosh, ... The Lancet Global Health 4 (8), e559-e567, 2016 | 175 | 2016 |
| Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia Y Shimakawa, M Lemoine, HF Njai, C Bottomley, G Ndow, RD Goldin, ... Gut 65 (12), 2007-2016, 2016 | 163 | 2016 |
| Systematic review with meta‐analysis: the risk of mother‐to‐child transmission of hepatitis B virus infection in sub‐Saharan Africa E Keane, AL Funk, Y Shimakawa Alimentary pharmacology & therapeutics 44 (10), 1005-1017, 2016 | 161 | 2016 |
| Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis AL Funk, Y Lu, K Yoshida, T Zhao, P Boucheron, J van Holten, R Chou, ... The Lancet Infectious Diseases 21 (1), 70-84, 2021 | 154 | 2021 |
| Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis S Nayagam, L Conteh, E Sicuri, Y Shimakawa, P Suso, S Tamba, R Njie, ... The Lancet Global Health 4 (8), e568-e578, 2016 | 125 | 2016 |
| Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis P Boucheron, Y Lu, K Yoshida, T Zhao, AL Funk, F Lunel-Fabiani, ... The Lancet Infectious Diseases 21 (1), 85-96, 2021 | 108 | 2021 |
| Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa HF Njai, Y Shimakawa, B Sanneh, L Ferguson, G Ndow, M Mendy, A Sow, ... Journal of clinical microbiology 53 (4), 1156-1163, 2015 | 104 | 2015 |
| Barriers to timely administration of birth dose vaccines in The Gambia, West Africa R Miyahara, M Jasseh, P Gomez, Y Shimakawa, B Greenwood, K Keita, ... Vaccine 34 (29), 3335-3341, 2016 | 97 | 2016 |
| Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C‐infected Egyptian cohort: a comparative analysis M El Kassas, AL Funk, M Salaheldin, Y Shimakawa, M Eltabbakh, K Jean, ... Journal of viral hepatitis 25 (6), 623-630, 2018 | 95 | 2018 |
| Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review Y Shimakawa, HJ Yan, N Tsuchiya, C Bottomley, AJ Hall PloS one 8 (7), e69430, 2013 | 92 | 2013 |
| Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia M Lemoine, Y Shimakawa, R Njie, HF Njai, S Nayagam, M Khalil, ... Alimentary pharmacology & therapeutics 39 (2), 188-196, 2014 | 79 | 2014 |
| Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans NG Ladep, AC Dona, MR Lewis, MME Crossey, M Lemoine, E Okeke, ... Hepatology 60 (4), 1291-1301, 2014 | 78 | 2014 |
| Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus A Llibre, Y Shimakawa, E Mottez, S Ainsworth, TP Buivan, R Firth, ... Gut 67 (11), 2017-2024, 2018 | 73 | 2018 |
| Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa Y Shimakawa, R Njie, G Ndow, M Vray, PS Mbaye, P Bonnard, R Sombié, ... Journal of hepatology 69 (4), 776-784, 2018 | 73 | 2018 |
| Time matters: point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England Z Mohamed, D Al-Kurdi, M Nelson, Y Shimakawa, N Selvapatt, J Lacey, ... International Journal of Drug Policy 75, 102608, 2020 | 62 | 2020 |
| Evaluation of data quality at the Gambia national cancer registry Y Shimakawa, E Bah, CP Wild, AJ Hall International Journal of Cancer 132 (3), 658-665, 2013 | 53 | 2013 |
| Hepatitis B core-related antigen: an alternative to hepatitis B virus DNA to assess treatment eligibility in Africa Y Shimakawa, G Ndow, R Njie, HF Njai, K Takahashi, SMF Akbar, ... Clinical Infectious Diseases 70 (7), 1442-1452, 2020 | 48 | 2020 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 47 | 2023 |
